TORO: Ninety-Six-Week Virologic and Immunologic Response and Safety Evaluation of Enfuvirtide with an Optimized Background of Antiretrovirals

Author:

Reynes Jacques1,Arastéh Keikawus2,Clotet Bonaventura3,Cohen Calvin4,Cooper David A.5,Delfraissy Jean-François6,Eron Joseph J.7,Henry Keith8,Katlama Christine9,Kuritzkes Daniel R.1011,Lalezari Jacob P.12,Lange Joep13,Lazzarin Adriano14,Montaner Julio S.G.15,Nelson Mark16,O' Hearn Mary17,Stellbrink Hans-Jürgen18,Trottier Benoit19,Walmsley Sharon L.20,Buss Neil E.21,DeMasi Ralph22,Chung Jain23,Donatacci Lucille23,Guimaraes Denise23,Rowell Lucy24,Valentine Adeline23,Wilkinson Martin24,Salgo Miklos P.23

Affiliation:

1. Hôpital Gui de Chauliac, CHU Montpellier, France.

2. EPIMED c/o Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.

3. Hospital Universitari Germans Trias i Pujol and the Institut de Recerca de la SIDA-Caixa Foundation, Badalona, Spain.

4. Community Research Initiative of New England, Boston, Massachusetts.

5. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.

6. Hôpital Bicêtre, Paris, France.

7. University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.

8. HIV Program, Hennepin County Medical Center, Minneapolis, Minnesota.

9. Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, Paris, France.

10. Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado.

11. Current address: Section of Retroviral Therapeutics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

12. Quest Clinical Research, San Francisco, California.

13. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

14. IRCCS, San Raffaele Vita-Salute University, Milan, Italy.

15. University of British Columbia, Vancouver, Canada.

16. Chelsea and Westminster Hospital, London, United Kingdom.

17. Oregon Health & Science University, School of Medicine, Portland, Oregon.

18. University Hospital Eppendorf, Hamburg, Germany.

19. Clinique Médicale l'Actuel, Montréal, Canada.

20. University Health Network, University of Toronto, Canada.

21. Roche, Basel, Switzerland.

22. Trimeris, Inc., Morrisville, North Carolina.

23. Roche, Nutley, New Jersey.

24. Roche, Welwyn, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Evaluating fostemsavir as a therapeutic option for patients with HIV;Expert Opinion on Pharmacotherapy;2021-06-14

2. Injectable Antiretroviral Drugs: Back to the Future;Viruses;2021-02-02

3. HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry;Journal of Biological Chemistry;2019-04

4. HIV-1 Entry Inhibitor Resistance;Handbook of Antimicrobial Resistance;2017

5. Antiretroviral Agent;Clinical Virology;2016-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3